Fujian Putan Thermal Energy Co., Ltd. signed a letter of intent to acquire Wuhan Lifecome Biochemistry Co.,Ltd. from Lifecome Biochemistry Co.,Ltd. for CNY 27.3 million
June 28, 2024
Share
Fujian Putan Thermal Energy Co., Ltd. signed a letter of intent to acquire Wuhan Lifecome Biochemistry Co.,Ltd. from Lifecome Biochemistry Co.,Ltd. (SZSE:002868) for CNY 27.3 million on June 27, 2024. A cash consideration of CNY 27.3 million will be paid by Fujian Putan Thermal Energy Co., Ltd.
As of March 31, 2024, Wuhan Lifecome Biochemistry Co.,Ltd. reported total assets of CNY 16.58 million and total common equity of CNY 16.77 million.
The transaction is subject to approval of merger agreement by target board. The deal has been approved by the board.
LIFECOME BIOCHEMISTRY CO LTD is a China-based company principally engaged in the development, production and sales of veterinary drugs. The Company's businesses include the production and sales of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives and biological pesticide. Its products include bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series and Jinggangmycin series. The Company distributes its products within domestic market and to overseas markets.
Fujian Putan Thermal Energy Co., Ltd. signed a letter of intent to acquire Wuhan Lifecome Biochemistry Co.,Ltd. from Lifecome Biochemistry Co.,Ltd. for CNY 27.3 million
LIFECOME BIOCHEMISTRY CO.,LTD. 
